Immune & Thymic
Thymalin
Also published as Thymus polypeptide extract
A polypeptide preparation extracted from calf thymus rather than a single synthesised sequence. That distinction matters more here than anywhere else in the catalogue, because batch definition is inherently harder for an extract.
Where it came from
Developed within the same St Petersburg peptide bioregulator programme that produced Epithalon, and used clinically in Russia from the 1980s.
What the literature examines
- T cell maturation and immune restoration in immunosuppressed models
- Age related immune decline
- Recovery after infection and surgery, in Russian clinical work
State of the evidence
Russian clinical use and literature. Very little independent Western study.
What a buyer should know
An extract is a mixture, not a molecule. Purity figures on an analysis certificate mean something different for an extract than they do for a synthesised peptide, and any buyer comparing a 99 percent figure on thymalin against 99 percent on a synthetic sequence is not comparing like with like.
Handling and stability
Lyophilised. Cold chain.
Read it yourself
We do not publish a curated citation list, because a hand picked list of papers is a sales tool. These links run a live query against the public databases, so you see everything, including the results that do not suit us.
Supplied for laboratory research use only. Nothing on this page is a dose, a protocol or a claim of effect in humans, and nothing here is medical advice. Read our research use policy.